ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-pxliv.xmlReviewer Page2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-pxliv.pdf2026-04-18Reviewer Pagehttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-pxxviii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-pxxviii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-pxli.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-pxli.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1505.xmlNCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.20172026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1505.pdf2026-04-18NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1495.xmlA Polycythemia Vera JAK2 Mutation Masquerading as a Duodenal Cancer Mutation2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1495.pdf2026-04-18A Polycythemia Vera JAK2 Mutation Masquerading as a Duodenal Cancer Mutationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1493.xmlPalliative Care—The Challenge of Application2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1493.pdf2026-04-18Palliative Care—The Challenge of Applicationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1491.xmlAn Oncologist's Letter to Santa2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1491.pdf2026-04-18An Oncologist's Letter to Santahttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1519.xmlFactors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer Center2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1519.pdf2026-04-18Factors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer Centerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1555.xmlEffective Translation of Research to Practice: Hospital-Based Rehabilitation Program Improves Health-Related Physical Fitness and Quality of Life of Cancer Survivors2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1555.pdf2026-04-18Effective Translation of Research to Practice: Hospital-Based Rehabilitation Program Improves Health-Related Physical Fitness and Quality of Life of Cancer Survivorshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1536.xmlDifferential Radiographic Appearance of BRAF V600E–Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1536.pdf2026-04-18Differential Radiographic Appearance of BRAF V600E–Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Locationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1548.xmlDelivery of Adjuvant Oxaliplatin for Colon Cancer: Insights From Routine Clinical Practice2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1548.pdf2026-04-18Delivery of Adjuvant Oxaliplatin for Colon Cancer: Insights From Routine Clinical Practicehttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1528.xmlNeoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1528.pdf2026-04-18Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1572.xmlMyeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1572.pdf2026-04-18Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1563.xmlPsychological Symptoms Among Patients With BCR-ABL–Negative Myeloproliferative Neoplasms2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1563.pdf2026-04-18Psychological Symptoms Among Patients With BCR-ABL–Negative Myeloproliferative Neoplasmshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1613.xmlDrug Development Pipeline for Myeloproliferative Neoplasms: Potential Future Impact on Guidelines and Management2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-p1613.pdf2026-04-18Drug Development Pipeline for Myeloproliferative Neoplasms: Potential Future Impact on Guidelines and Managementhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-pe1626.xmlExperience of Myeloproliferative Neoplasms Guidelines in the United Kingdom: Perspective and International Context2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/12/article-pe1626.pdf2026-04-18Experience of Myeloproliferative Neoplasms Guidelines in the United Kingdom: Perspective and International Context